Related Experiment Video

Updated: Jul 16, 2026

Functionalization of Atomic Force Microscope Cantilevers with Single-T Cells or Single-Particle for Immunological Single-Cell Force Spectroscopy
10:06

Functionalization of Atomic Force Microscope Cantilevers with Single-T Cells or Single-Particle for Immunological Single-Cell Force Spectroscopy

Published on: July 10, 2019

Stem cells. $2.2 million for cells to fight Parkinson's

C Holden

    Science (New York, N.Y.)
    |September 15, 2001
    PubMed

    Insights

    The Michael J. Fox Foundation is funding a $2.2 million initiative to create stem cell-derived dopamine neurons. This resource will be accessible to Parkinson's disease researchers globally.

    Area of Science:

    • Neuroscience
    • Stem Cell Biology
    • Neurodegenerative Diseases

    Background:

    • Parkinson's disease is characterized by the loss of dopamine-producing neurons.
    • Current research relies on limited access to essential cellular models.
    • Stem cell technology offers a promising avenue for disease modeling.

    Discussion:

    • The initiative aims to generate a standardized, renewable source of dopamine neurons.
    • This will facilitate research into Parkinson's disease mechanisms and potential therapies.
    • Accessibility for the wider research community is a key objective.

    Key Insights:

    • A $2.2 million investment will establish a critical stem cell-derived neuron line.
    • This resource is intended for broad distribution among Parkinson's researchers.
    • The project focuses on creating dopamine-producing neurons essential for Parkinson's studies.

    Outlook:

    • Accelerated development of novel Parkinson's disease treatments.
    • Enhanced understanding of disease pathology through accessible cellular models.
    • Potential for personalized medicine approaches in Parkinson's research.

    More Related Videos

    Establishment and Genetic Manipulation of Murine Hepatocyte Organoids14:54

    Establishment and Genetic Manipulation of Murine Hepatocyte Organoids

    Published on: February 12, 2022

    An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue10:33

    An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue

    Published on: February 3, 2023

    Related Concept Videos

    Satellite Stem Cells and Muscular Dystrophy01:21

    Satellite Stem Cells and Muscular Dystrophy

    Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
    Stem Cell Therapy for Tissue Regeneration01:21

    Stem Cell Therapy for Tissue Regeneration

    Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
    Types of Stem Cells used in Stem Cell Therapy
    The two main cell types that...
    iPS Cell Differentiation01:22

    iPS Cell Differentiation

    The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
    EPS and iPS Cells in Disease Research01:21

    EPS and iPS Cells in Disease Research

    Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...